This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Eric Alonzo
Scientist, Cellular Analytics at Bluebird Bio


Dr. Alonzo, currently leads the CAR T cell analytics team within the Pharmaceutical Sciences Division at bluebird bio. His primary role is developing the characterization strategy for all oncology programs at bluebird bio. Prior to bluebird bio, Dr. Alonzo lead efforts developing T cell-based therapies at Agenus (Lexington, MA), and previous to his work at Agenus, he a postdoctoral fellow at Massachusetts General Hospital and Harvard Medical School working on a mouse model of T cell acute lymphoblastic leukemia. Dr. Alonzo received his PhD from the Cancer Biology Program at Memorial Sloan-Kettering Cancer Center.

Agenda Sessions

  • Leveraging high-dimensional ‘-omics’ technologies for comprehensive profiling of CAR T cells to resolve drug product complexity